StreetAlpha.app
Home › Stocks › VTVT

vTv Therapeutics Inc. (VTVT)

$15.51
▼ −5.20%
LAST CLOSE · NOV 20

vTv Therapeutics develops oral medicines for metabolic and inflammatory diseases, led by a treatment being tested for type 1 diabetes. It last closed at $15.51 on Nov 20, down 5.20% on the day. The next earnings report for VTVT is expected around Tue, Mar 9, 2027, after the close. Over its last 8 reports the stock moved an average of 5.5% the session after earnings.

AI Auto Pilots
Is VTVT in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold VTVT.

Key Stats

Last 12 months
Results
Revenue
$36.8M
+216600.0% vs a year ago
Net income
−$7.7M
−20.8% margin
Operating margin
−29.8%
−$11.0M operating income
Balance sheet
Cash & equivalents
$77.2M
At Sep 30
Shareholder equity
$69.7M
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $4.0M$4.0MFY2021FY2022: $2.0M$2.0MFY2022FY2023: $0$0FY2023FY2024: $1.0M$1.0MFY2024FY2025: $0$0FY2025

From VTVT's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Next report
Mar 9
Estimated date · After the close
Reported EPS
—
Quarter ended Sep 2026
Year ago EPS
—
Same quarter last year
Revenue
$0
Last reported quarter
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Not enough quarters on file yet.
Revenue by quarter
Dec 2024: $17,000Dec '24Mar 2025: $0Mar '25Jun 2025: $0Jun '25Sep 2025: $0Sep '25Dec 2025: $0Dec '25Mar 2026: $36.8MMar '26Jun 2026: $0Jun '26Sep 2026: $0Sep '26Latest $0
How VTVT moved after its last 8 reports
Average move the session after a report ±5.5%
Nov 5, 2026After the close−3.3%
Aug 6, 2026After the close+2.2%
May 13, 2026After the close+21.4%
Mar 10, 2026After the close+0.2%
Nov 6, 2025After the close+2.2%
Aug 12, 2025After the close−3.2%
May 15, 2025After the close−6.2%
Mar 20, 2025After the close−5.5%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on VTVTStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on VTVT
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on VTVT

Technical Analysis

VTVT · as of the Nov 20 close · updated each morning
Downtrend, oversold

The stock is 39% below its 20 day and 70% below its 50 day average. It is 109% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 16), oversold. The nearest support is the 52 week low at $15.47, and the nearest resistance the Pivot at $15.83.

Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityNormal, 9.2%/day
Key levels
$44.0052 week high+183.7%
$32.39200 day average+108.8%
$29.58100 day average+90.7%
$27.01Swing high (Oct 29)+74.1%
$26.4450 day average+70.5%
$21.5220 day average+38.7%
$16.20Pivot R1+4.4%
$15.83Pivot+2.1%
$15.51Last close
$15.4752 week low−0.3%
$15.15Pivot S1−2.3%
Indicators
RSI (14)15.94Oversold below 30Oversold
MACD-3.03Below its signal lineBearish
Stochastic3.2Near the bottom of its rangeOversold
ADX (14)43.0Strong downtrend
Williams %R-99.6Oversold below −80, overbought above −20Oversold
CCI (20)-136.7Oversold below −100, overbought above 100Oversold
Rate of change−26.3%Change over 10 sessionsBearish
ATR (14)$1.42Typical daily range, 9.2% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for VTVT

What happened before

See how VTVT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow VTVT usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How VTVT has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2015.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for VTVTHow many large options trades hit VTVT, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

VTVT Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ▼17 buying vs 21 selling
  • ▲Shares held by funds +8.5%
  • ▼Funds holding -7
  • ●Superinvestors: 2 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding3845−15.6%
In funds' top 1000–
Held by funds–––
New / increased5 / 1217 / 6−26.1%
Reduced / sold out9 / 128 / 6+50.0%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See VTVT institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

VTVT Insider Trading

All filings →
Insider trading · 12 months
No open market trades in 12 months
Bought$00 buys · 0 insiders
Sold$00 sales · 0 insiders
DecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 18, 2024Paul J SekhriPres, CEO and Exec ChairpersonBuy5,000$16.76$84K
Every insider buy and sale for VTVT over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See VTVT insider trades →

From SEC Form 4 filings by VTVT's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether VTVT is in one of them and how their past VTVT trades turned out.

VTVT in the AI portfolios
Loading…

VTVT News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered VTVT in an article yet. Here's the latest on the wider market.

VTVT in the news

About vTv Therapeutics

vTv Therapeutics is a biopharmaceutical company based in High Point, North Carolina. It develops oral medicines for metabolic and inflammatory diseases. Its main product candidate, cadisegliatin, is being tested as a medicine taken by mouth alongside insulin for people with type 1 diabetes, a condition in which the body stops producing insulin. The company also works with partners on its other drug candidates.

Headquarters
High Point, NC